Alkermes plc

09/23/2024 | Press release | Distributed by Public on 09/23/2024 05:55

Alkermes to Present Positive Clinical Data From Phase 1b Study of ALKS 2680 in Patients With Narcolepsy Type 2 and Idiopathic Hypersomnia at Sleep Europe 2024